Alzheimer’s

The failure of a more-than-decade-long trial in patients with early-onset Alzheimer’s deals yet another blow to a key treatment theory, observers say.

For some reason, it seems like practitioners run away from diagnosing people with Alzheimer’s disease. I don’t understand that when, in fact, Alzheimer’s disease accounts for 75% to 80% of all dementias. ...

Principle LTC, operator of 45 nursing homes in the Southeast, is building on its successful role in testing a key drug for COVID-19 prevention and treatment to launch trials of a new Alzheimer drug.

Midlife obesity, physical inactivity and low education are three prominent modifiable risk factors tied to dementia, researchers say.

Medicare Advantage plans will be more incentivized to address gaps in care if consumer care assessments include more input from enrollees with dementia, investigators say.

Table top gaming consoles — so-called magic tables — are taking off in memory care communities, providing an easy way to stimulate the brains of those with memory impairing diseases.

Frequent, unsubtle symptoms have a big impact on patient quality of life, but are often unreported in primary care, investigators report.

A healthy lifestyle can go a long way to adding years to your life, but it might not help those with Alzheimer’s disease and dementia.

To boost or not to boost: Providers tackle the question … Exercise may protect against brain volume loss due to aging, investigators say … FDA delays REGEN-COV approval decision to July … U.S. economic...

Coverage of aducanumab (Aduhelm) is officially limited to clinical trials only, the agency announced Thursday. Most stakeholders have called for restricted use while more efficacy and safety data is gathered,...